{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:02:55Z","timestamp":1790704975466,"version":"4.1.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004271","name":"Sapienza University of Rome","doi-asserted-by":"publisher","award":["RM11715C586062AF"],"award-info":[{"award-number":["RM11715C586062AF"]}],"id":[{"id":"10.13039\/501100004271","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.cyto.2019.01.012","type":"journal-article","created":{"date-parts":[[2019,3,23]],"date-time":"2019-03-23T03:27:30Z","timestamp":1553311650000},"page":"273-281","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Increased expression of IL-32 correlates with IFN-\u03b3, Th1 and Tc1 in virologically suppressed HIV-1-infected patients"],"prefix":"10.1016","volume":"120","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5621-058X","authenticated-orcid":false,"given":"Letizia","family":"Santinelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maura","family":"Statzu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Pierangeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Frasca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6024-9540","authenticated-orcid":false,"given":"Alessia","family":"Bressan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Pinacchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Nonne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ombretta","family":"Turriziani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Antonelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"d'Ettorre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1044-1478","authenticated-orcid":false,"given":"Carolina","family":"Scagnolari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.cyto.2019.01.012_b0005","first-page":"131","article-title":"Interleukin-32: a cytokine and inducer of TNF alpha","volume":"22","author":"Kim","year":"2005","journal-title":"Immunity"},{"issue":"20","key":"10.1016\/j.cyto.2019.01.012_b0010","doi-asserted-by":"crossref","first-page":"3883","DOI":"10.1007\/s00018-013-1301-9","article-title":"Novel insights into the biology of interleukin-32","volume":"70","author":"Joosten","year":"2013","journal-title":"Cell Mol. Life Sci."},{"issue":"9","key":"10.1016\/j.cyto.2019.01.012_b0015","doi-asserted-by":"crossref","first-page":"5056","DOI":"10.4049\/jimmunol.0902667","article-title":"IL-32: A host proinflammatory factor against influenza viral replication is upregulated by aberrant epigenetic modifications during influenza A virus infection","volume":"185","author":"Li","year":"2010","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.cyto.2019.01.012_b0020","doi-asserted-by":"crossref","first-page":"4110","DOI":"10.4049\/jimmunol.1000081","article-title":"Protection from RNA and DNA viruses by IL-32","volume":"186","author":"Zepp","year":"2011","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.cyto.2019.01.012_b0025","doi-asserted-by":"crossref","first-page":"e277","DOI":"10.1371\/journal.pmed.0030277","article-title":"Mycobacterium tuberculosis induces interleukin-32 production through a caspase- 1\/IL-18\/interferon-gamma-dependent mechanism","volume":"3","author":"Netea","year":"2006","journal-title":"PLoS Med."},{"issue":"29","key":"10.1016\/j.cyto.2019.01.012_b0030","doi-asserted-by":"crossref","first-page":"20927","DOI":"10.1074\/jbc.M112.440115","article-title":"Inducible interleukin 32 (IL-32) exerts extensive antiviral function via selective stimulation of interferon \u03bb1 (IFN-\u03bb1)","volume":"288","author":"Li","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.cyto.2019.01.012_b0035","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1002\/hep.24285","article-title":"Interleukin-32: A new proinflammatory cytokine involved in hepatitis C virus-related liver inflammation and fibrosis","volume":"53","author":"Moschen","year":"2011","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cyto.2019.01.012_b0040","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.imlet.2008.01.007","article-title":"Increased level of IL-32 during human immunodeficiency virus infection suppresses HIV replication","volume":"117","author":"Rasool","year":"2008","journal-title":"Immunol Lett."},{"issue":"1","key":"10.1016\/j.cyto.2019.01.012_b0045","doi-asserted-by":"crossref","first-page":"557","DOI":"10.4049\/jimmunol.181.1.557","article-title":"Endogenous IL-32 controls cytokine and HIV-1 production","volume":"181","author":"Nold","year":"2008","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.cyto.2019.01.012_b0050","doi-asserted-by":"crossref","first-page":"6576","DOI":"10.4049\/jimmunol.1100277","article-title":"The immunosuppressive role of IL-32 in lymphatic tissue during HIV-1 infection","volume":"186","author":"Smith","year":"2011","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.cyto.2019.01.012_b0055","first-page":"207","article-title":"Interleukin-32 isoforms: expression, interaction with interferon-regulated genes and clinical significance in chronically HIV-1-infected patients","volume":"203","author":"Monteleone","year":"2014","journal-title":"Med. Microbiol. Immunol."},{"issue":"6","key":"10.1016\/j.cyto.2019.01.012_b0060","doi-asserted-by":"crossref","first-page":"22902","DOI":"10.1038\/srep22902","article-title":"Investigators of the Canadian HIV+ slow progressor cohort. Proinflammatory isoforms of IL-32 as novel and robust biomarkers for control failure in HIV-infected slow progressors","volume":"15","author":"El-Far","year":"2016","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.cyto.2019.01.012_b0065","first-page":"614","article-title":"Role of interleukin 32 in human immunodeficiency virus reactivation and its link to human immunodeficiency virus-herpes simplex virus coinfection","volume":"215","author":"Mesquita","year":"2017","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.cyto.2019.01.012_b0070","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.cytogfr.2018.03.003","article-title":"Type I interferon and HIV: Subtle balance between antiviral activity, immunopathogenesis and the microbiome","volume":"40","author":"Scagnolari","year":"2018","journal-title":"Cytokine Growth Factor Rev."},{"issue":"4","key":"10.1016\/j.cyto.2019.01.012_b0075","first-page":"498","article-title":"The significance of interferon-\u03b3 in HIV-1 pathogenesis, therapy, and prophylaxis","volume":"13","author":"Roff","year":"2014","journal-title":"Front Immunol."},{"issue":"6","key":"10.1016\/j.cyto.2019.01.012_b0080","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.3390\/v7062762","article-title":"Important role of the IL-32 inflammatory network in the host response against viral infection","volume":"7","author":"Zhou","year":"2015","journal-title":"Viruses"},{"key":"10.1016\/j.cyto.2019.01.012_b0085","doi-asserted-by":"crossref","first-page":"8413768","DOI":"10.1155\/2016\/8413768","article-title":"IL-32: A Novel Pluripotent Inflammatory Interleukin, towards Gastric Inflammation, Gastric Cancer, and Chronic Rhino Sinusitis","volume":"2016","author":"Khawar","year":"2016","journal-title":"Mediators Inflamm."},{"issue":"38","key":"10.1016\/j.cyto.2019.01.012_b0090","doi-asserted-by":"crossref","first-page":"40452","DOI":"10.18632\/oncotarget.6306","article-title":"Myelin oligodendrocyte glycoprotein (MOG35-55)-induced experimental autoimmune encephalomyelitis is ameliorated in interleukin-32 alpha transgenic mice","volume":"6","author":"Yun","year":"2015","journal-title":"Oncotarget."},{"key":"10.1016\/j.cyto.2019.01.012_b0095","doi-asserted-by":"crossref","first-page":"41629","DOI":"10.1038\/srep41629","article-title":"IL-32 promoter SNP rs4786370 predisposes to modified lipoprotein profiles in patients with rheumatoid arthritis","volume":"7","author":"Damen","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cyto.2019.01.012_b0100","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1038\/srep02960","article-title":"IL-32-PAR2 axis is an innate immunity sensor providing alternative signaling for LPS-TRIF axis.","volume":"3","author":"Nakayama","year":"2013","journal-title":"Sci Rep."},{"issue":"2","key":"10.1016\/j.cyto.2019.01.012_b0105","doi-asserted-by":"crossref","first-page":"e1701729","DOI":"10.1126\/sciadv.1701729","article-title":"PD Katsikis, T Mahmoudi. Allele-specific long-distance regulation dictates IL-32 isoform switching and mediates susceptibility to HIV-1","volume":"4","author":"Palstra","year":"2018","journal-title":"Sci Adv."},{"key":"10.1016\/j.cyto.2019.01.012_b0110","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.cytogfr.2012.05.001","article-title":"The role of cytokines in the establishment, persistence and eradication of the HIV reservoir","volume":"23","author":"Vandergeeten","year":"2012","journal-title":"Cytokine Growth Factor Rev."},{"issue":"50","key":"10.1016\/j.cyto.2019.01.012_b0115","doi-asserted-by":"crossref","first-page":"19851","DOI":"10.1073\/pnas.0810032105","article-title":"HIV infection-associated immune activation occurs by two distinct pathways that differentially affect CD4 and CD8 T cells","volume":"105","author":"Catalfamo","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.cyto.2019.01.012_b0120","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0960-5428(95)00012-Q","article-title":"Role of immune activation and cytokine expression in HIV-1-associated neurologic diseases","volume":"5","author":"Yoshioka","year":"1995","journal-title":"Adv. Neuroimmunol."},{"key":"10.1016\/j.cyto.2019.01.012_b0125","doi-asserted-by":"crossref","first-page":"395484","DOI":"10.1155\/2015\/395484","article-title":"C Scagnolari analysis of Th17 and Tc17 frequencies and antiviral defenses in gut-associated lymphoid tissue of chronic HIV-1 positive patients","volume":"2015","author":"d'Ettorre","year":"2015","journal-title":"Mediators Inflamm."},{"issue":"8","key":"10.1016\/j.cyto.2019.01.012_b0130","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1089\/aid.2007.0261","article-title":"Interferon-gamma receptors in HIV-1 infection","volume":"24","author":"Koirala","year":"2008","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"9","key":"10.1016\/j.cyto.2019.01.012_b0135","doi-asserted-by":"crossref","first-page":"4386","DOI":"10.1073\/pnas.93.9.4386","article-title":"Kinetics of cytokine expression during primary human immunodeficiency virus type 1 infection","volume":"93","author":"Graziosi","year":"1996","journal-title":"PNAS April 30"},{"issue":"1","key":"10.1016\/j.cyto.2019.01.012_b0140","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.cyto.2014.08.010","article-title":"Variability of cytokine gene expression in intestinal tissue and the impact of normalization with the use of reference genes","volume":"71","author":"McGowan","year":"2015","journal-title":"Cytokine"},{"issue":"5","key":"10.1016\/j.cyto.2019.01.012_b0145","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0016-5085(99)70014-4","article-title":"Rapid mucosal CD4(+) T-cell depletion and enteropathy in simian immunodeficiency virus-infected rhesus macaques","volume":"116","author":"Kewenig","year":"1999","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.cyto.2019.01.012_b0150","doi-asserted-by":"crossref","first-page":"6646","DOI":"10.1128\/JVI.72.8.6646-6656.1998","article-title":"Gastrointestinal T lymphocytes retain high potential for cytokine responses but have severe CD4(+) T-cell depletion at all stages of simian immunodeficiency virus infection compared to peripheral lymphocytes","volume":"72","author":"Smit-McBride","year":"1998","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/j.cyto.2019.01.012_b0155","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1177\/095632020101200301","article-title":"Cytokines and HIV- 1: interactions and clinical implications","volume":"12","author":"Kedzierska","year":"2001","journal-title":"Antivir. Chem. Chemother."},{"issue":"6","key":"10.1016\/j.cyto.2019.01.012_b0160","doi-asserted-by":"crossref","first-page":"R166","DOI":"10.1186\/ar2074","article-title":"Interactions between IL-32 and tumor necrosis factor alpha contribute to the exacerbation of immune-inflammatory diseases","volume":"8","author":"Shoda","year":"2006","journal-title":"Arthritis Res. Ther."},{"issue":"2","key":"10.1016\/j.cyto.2019.01.012_b0165","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.cyto.2012.07.010","article-title":"Interleukin- 32: a predominantly intracellular proinflammatory mediator that controls cell activation and cell death","volume":"60","author":"Heinhuis","year":"2012","journal-title":"Cytokine"},{"issue":"45","key":"10.1016\/j.cyto.2019.01.012_b0170","doi-asserted-by":"crossref","first-page":"16309","DOI":"10.1073\/pnas.0508237102","article-title":"IL-32 synergizes with nucleotide oligomerization domain (NOD) 1 and NOD2 ligands for IL-1beta and IL-6 production through a caspase 1-dependent mechanism","volume":"102","author":"Netea","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.cyto.2019.01.012_b0175","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s11904-009-0038-4","article-title":"Early immune senescence in HIV disease","volume":"7","author":"Desai","year":"2010","journal-title":"Curr HIV\/AIDS Rep."},{"issue":"5","key":"10.1016\/j.cyto.2019.01.012_b0180","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1111\/bjd.15458","article-title":"Interleukin-32 is highly expressed in lesions of hidradenitis suppurativa","volume":"177","author":"Thomi","year":"2017","journal-title":"Br. J. Dermatol."},{"issue":"1","key":"10.1016\/j.cyto.2019.01.012_b0185","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1365-2249.1991.tb08132.x","article-title":"Altered production of tumour necrosis factors alpha and beta and interferon gamma by HIV-infected individuals","volume":"84","author":"Vyakarnam","year":"1991","journal-title":"Clin Exp Immunol."},{"key":"10.1016\/j.cyto.2019.01.012_b0190","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1471-2172-2-10","article-title":"HIV infection and aging: enhanced Interferon- and Tumor Necrosis Factor-alpha production by the CD8+ CD28- T subset","volume":"2","author":"Eylar","year":"2001","journal-title":"BMC Immunol."},{"issue":"3","key":"10.1016\/j.cyto.2019.01.012_b0195","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1365-2567.2008.02905.x","article-title":"Secretion of interferon-\u03b3 by human macrophages demonstrated at the single-cell level after costimulation with interleukin (IL)-12 plus IL-18","volume":"126","author":"Darwich","year":"2009","journal-title":"Immunology"},{"issue":"2","key":"10.1016\/j.cyto.2019.01.012_b0200","first-page":"745","article-title":"Loss of IL-17-producing CD8 T cells during late chronic stage of pathogenic simian immunodeficiency virus infection","volume":"186","author":"Nigam","year":"2011","journal-title":"J. Immunol. Baltim. Md. 1950"},{"issue":"4","key":"10.1016\/j.cyto.2019.01.012_b0205","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1097\/QAD.0b013e32835b8cb3","article-title":"CD3+CD8+CD161high Tc17 cells are depleted in HIV-infection","volume":"27","author":"Gaardbo","year":"2013","journal-title":"AIDS Lond Engl."},{"issue":"19","key":"10.1016\/j.cyto.2019.01.012_b0210","doi-asserted-by":"crossref","first-page":"12164","DOI":"10.1128\/JVI.79.19.12164-12172.2005","article-title":"Temporal and anatomic relationship between virus replication and cytokine gene expression after vaginal simian immunodeficiency virus infection","volume":"79","author":"Abel","year":"2005","journal-title":"J. Virol."},{"issue":"6","key":"10.1016\/j.cyto.2019.01.012_b0215","first-page":"391","article-title":"Variation in the expression of human immunodeficiency virus RNA and cytokine mRNA in rectal mucosa during the progression of infection","volume":"13","author":"Reka","year":"1994","journal-title":"Lymphokine Cytokine Res."},{"issue":"6","key":"10.1016\/j.cyto.2019.01.012_b0220","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1086\/317625","article-title":"Human immunodeficiency virus type 1 infection is associated with significant mucosal inflammation characterized by increased expression of CCR5, CXCR4, and beta-chemokines","volume":"182","author":"Olsson","year":"2000","journal-title":"J. Infect. Dis."},{"issue":"2","key":"10.1016\/j.cyto.2019.01.012_b0225","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1097\/01.qai.0000131846.12453.29","article-title":"Increased HIV-1 mucosal replication is associated with generalized mucosal cytokine activation","volume":"37","author":"McGowan","year":"2004","journal-title":"JAIDS J. Acquired Immune Deficiency Syndromes"},{"issue":"28","key":"10.1016\/j.cyto.2019.01.012_b0230","doi-asserted-by":"crossref","first-page":"9860","DOI":"10.1073\/pnas.0503463102","article-title":"Gut mucosal T cell responses and gene expression correlate with protection against disease in long-term HIV-1-infected nonprogressors","volume":"102","author":"Sankaran","year":"2005","journal-title":"PNAS"},{"issue":"4","key":"10.1016\/j.cyto.2019.01.012_b0235","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1365-2567.2008.02917.x","article-title":"Identification of the most active interleukin-32 isoform","volume":"126","author":"Choi","year":"2009","journal-title":"Immunology"},{"issue":"1","key":"10.1016\/j.cyto.2019.01.012_b0240","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.cellimm.2010.04.010","article-title":"Downregulation of immune response by the human cytokines Interleukin-32alpha and beta in cell-mediated rejection","volume":"264","author":"Chae","year":"2010","journal-title":"Cell. Immunol."},{"issue":"3","key":"10.1016\/j.cyto.2019.01.012_b0245","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/oby.21001","article-title":"Interleukin-32\u03b2 ameliorates metabolic disorder and liver damage in mice fed high-fat diet","volume":"23","author":"Lee","year":"2015","journal-title":"Obesity"},{"key":"10.1016\/j.cyto.2019.01.012_b0250","doi-asserted-by":"crossref","first-page":"3776","DOI":"10.1016\/j.febslet.2013.10.019","article-title":"Interleukin-32\u03b4 interacts with IL-32\u03b2 and inhibits IL-32\u03b2-mediated IL-10 production","volume":"587","author":"Kang","year":"2013","journal-title":"FEBS Lett."},{"key":"10.1016\/j.cyto.2019.01.012_b0255","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.4014\/jmb.1404.04012","article-title":"Interleukin-32\u03b3 transgenic mice resist LPS-mediated septic shock","volume":"24","author":"Kim","year":"2014","journal-title":"J. Microbiol. Biotechnol."},{"key":"10.1016\/j.cyto.2019.01.012_b0260","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.biochi.2014.01.013","article-title":"Interaction network mapping among IL-32 isoforms","volume":"101","author":"Kang","year":"2014","journal-title":"Biochimie"},{"issue":"7","key":"10.1016\/j.cyto.2019.01.012_b0265","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/M14-1084","article-title":"JS Currier; ACTG A5257 Team. Efficacy and tolerability of 3 nonnucleoside reverse transcriptase inhibitor-sparing antiretroviral regimens for treatment-naive volunteers infected with HIV- 1: a randomized, controlled equivalence trial","volume":"161","author":"Lennox","year":"2014","journal-title":"Ann. Intern. Med."},{"issue":"4","key":"10.1016\/j.cyto.2019.01.012_b0270","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/cid\/civ327","article-title":"Changes in inflammation and immune activation with Atazanavir-, Raltegravir-, Darunavir-based initial antiviral therapy: ACTG 5260s","volume":"61","author":"Kelesidis","year":"2015","journal-title":"Clin. Infect. Dis."},{"issue":"11","key":"10.1016\/j.cyto.2019.01.012_b0275","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1097\/QAD.0b013e32833a608a","article-title":"SPIRAL Study Group. Substitution of raltegravir for ritonavir-boosted protease inhibitors in HIV-infected patients: the SPIRAL study","volume":"24","author":"Mart\u00ednez","year":"2010","journal-title":"AIDS"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466619300365?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466619300365?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T20:55:50Z","timestamp":1760907350000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466619300365"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":55,"alternative-id":["S1043466619300365"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2019.01.012","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased expression of IL-32 correlates with IFN-\u03b3, Th1 and Tc1 in virologically suppressed HIV-1-infected patients","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2019.01.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}